{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T21:42:25Z","timestamp":1758922945527},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.path.2010.12.003","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T10:03:39Z","timestamp":1298455419000},"page":"261-274","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Approach to Diagnosis and Management of Ovarian, Fallopian Tube, and Peritoneal Carcinoma"],"prefix":"10.1016","volume":"4","author":[{"given":"David F.","family":"Silver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadim","family":"Bou-Zgheib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2010.12.003_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.path.2010.12.003_bib2","series-title":"GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0","author":"Ferlay","year":"2004"},{"key":"10.1016\/j.path.2010.12.003_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","article-title":"Focus on epithelial ovarian cancer","volume":"5","author":"Ozols","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.path.2010.12.003_bib4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Rish","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.path.2010.12.003_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2010.12.003_bib6","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1001\/jama.1993.03510230051034","article-title":"Tubal ligation, hysterectomy, and risk of ovarian cancer: a prospective study","volume":"270","author":"Hankinson","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.path.2010.12.003_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Rish","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.path.2010.12.003_bib8","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.path.2010.12.003_bib9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA1, BRCA2 and hereditary nonpoliposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing","volume":"178","author":"Rubin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.path.2010.12.003_bib11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenasi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2010.12.003_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.path.2010.12.003_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected fro family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.path.2010.12.003_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.path.2010.12.003_bib15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(02)11023-3","article-title":"Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study","volume":"360","author":"Bergfeldt","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.path.2010.12.003_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0002-9440(10)62549-7","article-title":"Diverse tumorigenic pathways in ovarian serous carcinoma","volume":"160","author":"Singer","year":"2002","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.path.2010.12.003_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2010.12.003_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00003081-200609000-00004","article-title":"Screening for ovarian cancer","volume":"49","author":"Rosenthal","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib20","first-page":"759","article-title":"Screening for ovarian cancer: recommendation statement. U.S. Preventive Services Task Force","volume":"71","author":"U.S. Preventive Services Task Force","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.path.2010.12.003_bib21","author":"American Cancer Society"},{"key":"10.1016\/j.path.2010.12.003_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.2002.6865","article-title":"The role of the generalist obstetrician-gynecolgist in the early detection of ovarian cancer","volume":"87","author":"ACOG Committee on Gynecologic Practice","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib24","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2010.12.003_bib25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2010.12.003_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with BRCA 1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.path.2010.12.003_bib27","series-title":"NCCN Clinical Practice Guidelines in Oncology. Hereditary breast and or ovarian cancer. Version 1.2006, December 14, 2005","year":"2005"},{"key":"10.1016\/j.path.2010.12.003_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ajog.2004.04.028","article-title":"Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy","volume":"191","author":"Dowdy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0090-8258(92)90107-T","article-title":"The impact of the subspecialty training on the management of advanced ovarian cancer","volume":"47","author":"Eisenkop","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0090-8258(92)90110-5","article-title":"Ovarian cancer staging: does it require a gynecologic oncologist?","volume":"47","author":"Mayer","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib31","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0029-7844(02)02630-3","article-title":"ACOG Committee Opinion No. 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer","volume":"100","author":"American College of Obstetricians and Gynecologists","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0090-8258(86)90092-2","article-title":"Staging announcement: FIGO cancer committee","volume":"25","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib33","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1001\/jama.1983.03340220040030","article-title":"Staging laparotomy in early ovarian cancer","volume":"250","author":"Young","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.path.2010.12.003_bib34","first-page":"226","article-title":"Surgical staging of carcinoma of the ovaries","volume":"169","author":"Bushsbaum","year":"1989","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.path.2010.12.003_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ygyno.2006.06.013","article-title":"Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study","volume":"102","author":"Bell","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2010.12.003_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trail","volume":"95","author":"Trimbos","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.path.2010.12.003_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/95.2.125","article-title":"International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer","volume":"95","author":"Colombo","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"18S","key":"10.1016\/j.path.2010.12.003_bib38","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1200\/jco.2007.25.18_suppl.5509","article-title":"Long-term follow-up of women enrolled in a randomized trial of adjuvant chemotherpay for early stage ovarian cancer (ICON1)","volume":"25","author":"Swart","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.105","article-title":"International Collaborative Ovarian Neoplasm trial 1 and Adjuvant Chemotherapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma","volume":"95","author":"Trimbos","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.path.2010.12.003_bib40","first-page":"CD004706","article-title":"Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer","volume":"3","author":"Winter-Roach","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.path.2010.12.003_bib41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/oxfordjournals.annonc.a059355","article-title":"Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica","volume":"6","author":"Bolis","year":"1995","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.path.2010.12.003_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1008399414923","article-title":"Randomized study on adjuvant chemotherapy in stage I high risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument","volume":"11","author":"Trope","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2008.07.058","article-title":"Cytoreduction vs neoadjuvant chemotherapy for ovarian cancer","volume":"111","author":"Chi","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib44","unstructured":"Vergote I, Trope CG, Amant F, et\u00a0al. EORTC-GCG\/NCIC-CTG Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer (OVCA). Presented at the 12th Biennial meeting International Gynecologic Cancer Society-IGCS. Bangkok (Thailand), October 25\u201328, 2008."},{"key":"10.1016\/j.path.2010.12.003_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2010.12.003_bib46","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2010.12.003_bib47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib48","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/j.path.2010.12.003_bib49","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib51","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib52","first-page":"9","article-title":"Extensive cytoreductive surgery in advanced ovarian carcinoma","volume":"18","author":"Michel","year":"1997","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9378(92)91345-B","article-title":"Cytoreductive surgery for advanced stages of ovarian cancer","volume":"166","author":"Dauplat","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib56","first-page":"879","article-title":"Modified posterior exenteration for ovarian cancer","volume":"78","author":"Eisenkop","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib57","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.ygyno.2008.07.055","article-title":"Colon resection for ovarian cancer: intraoperative decisions","volume":"111","author":"Hoffman","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib58","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2009.05.037","article-title":"Extended left colon resections as part of complete cytoreduction for ovarian cancer: tips and considerations","volume":"114","author":"Silver","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib59","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1072-7515(01)01090-0","article-title":"Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer","volume":"193","author":"Gillette-Cloven","year":"2001","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.path.2010.12.003_bib60","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.clon.2007.06.015","article-title":"The role of bowel surgery with cytoreduction for epithelial ovarian cancer","volume":"19","author":"Cai","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0090-8258(82)90012-9","article-title":"Lower urinary tract resection as part of cytoreductive surgery for ovarian cancer","volume":"13","author":"Berek","year":"1982","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib62","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ajog.2006.03.072","article-title":"Ureteral surgery performed by a university gynecologic oncology service","volume":"195","author":"Hoffman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib63","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/gyno.1994.1142","article-title":"Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer","volume":"53","author":"Guidozzi","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib64","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ygyno.2005.08.036","article-title":"Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer","volume":"100","author":"Eisenkop","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib65","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ygyno.2008.07.053","article-title":"Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy\/resection, splenectomy, and distal pancreatectomy","volume":"111","author":"Kehoe","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib66","doi-asserted-by":"crossref","first-page":"209.e1","DOI":"10.1016\/j.ajog.2007.04.049","article-title":"Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection","volume":"197","author":"Hoffman","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2004.07.046","article-title":"Full-thickness diaphragmatic resection with simple and secure closure to accomplish complete cytoreductive surgery for patients with ovarian cancer","volume":"95","author":"Silver","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib68","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jamcollsurg.2006.06.027","article-title":"Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer","volume":"203","author":"Aletti","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.path.2010.12.003_bib69","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.ajog.2006.06.068","article-title":"Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer","volume":"195","author":"Aletti","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.003_bib70","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ygyno.2006.10.010","article-title":"The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions","volume":"104","author":"Juretzka","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib71","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/gyno.2001.6313","article-title":"Procedures required to accomplish complete cytoredution of ovarian cancer: is there a correlation with \u201cBiological Aggressiveness\u201d and survival?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2010.12.003_bib73","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib74","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(09)61157-0","article-title":"Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial","volume":"374","author":"Katsumata","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.path.2010.12.003_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2005.07.123","article-title":"Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib76","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","article-title":"The effect of debulking surgery after chemotherapy on the prognosis in advanced epithelial ovarian cancer","volume":"332","author":"Van Der Burg","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"Pt 1","key":"10.1016\/j.path.2010.12.003_bib78","first-page":"201a","article-title":"A\u00a0phase III randomised study of interval secondary surgery in patients with advanced stage ovarian carcinoma with suboptimal residual disease: a Gynecologic Oncology Group study","volume":"21","author":"Rose","year":"2002","journal-title":"Proc Amer Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2010.12.003_bib79","first-page":"89","article-title":"Neoadjuvant chemotherapy in stage III & IV epithelial ovarian carcinoma (EOC)","volume":"16","author":"Kumar","year":"2003","journal-title":"J Int Med Soc Acad"},{"key":"10.1016\/j.path.2010.12.003_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1998.5236","article-title":"Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival","volume":"72","author":"Swartz","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib82","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0936-6555(05)80227-4","article-title":"Neoadjuvant carboplatin and Ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma","volume":"5","author":"Lim","year":"1993","journal-title":"Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib83","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-8258(91)90335-3","article-title":"Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer","volume":"42","author":"Jacob","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib84","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","article-title":"Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib85","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.1992.10.4.513","article-title":"Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population","volume":"10","author":"Markman","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib86","first-page":"903b","article-title":"Ovarian cancer","volume":"52","author":"Sonoda","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.path.2010.12.003_bib87","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib88","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0090-8258(03)00399-8","article-title":"Phase II trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer","volume":"90","author":"Markman","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib89","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1200\/JCO.1994.12.11.2301","article-title":"Phase II trial of Docetaxel in patients with platinum-refractory advanced ovarian cancer","volume":"12","author":"Francis","year":"1994","journal-title":"Clin Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib90","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/annonc\/mdl376","article-title":"Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatinum is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial","volume":"18","author":"Ferrero","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib91","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer; the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"The ICON and AGO Collaborators","year":"2003","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.path.2010.12.003_bib92","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ijgc-00009577-200505001-00007","article-title":"Combination therapy with gemcitabine and carboplatinum in recurrent ovarian cancer","volume":"15","author":"Ago-Ovar Ncic Ctg & EORTC GCG","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.path.2010.12.003_bib93","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2009.05.004","article-title":"Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome","volume":"114","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.003_bib94","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized recurrent epithelial ovarian cancer. Analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.path.2010.12.003_bib95","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.path.2010.12.003_bib96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918110002539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918110002539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T21:07:24Z","timestamp":1592341644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918110002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1875918110002539"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2010.12.003","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}